Medi Caps Ltd share price softened by 0.85% to Rs 26.75 after the company's net profit witnessed a sharp fall of 173.36% to Rs 2.23 crore, while revenue from operations nosedived 20.47% to Rs 2.72 crore in Q2FY26 over Q1FY26. The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 24.84 lakh crore, easing 5.02%. It has improved by 1.04% over last one week and heading higher by 11.64% in last one month while the market capitalization of Medi Caps Ltd has inched up 3.30% and 13.56% in the same period respectively. Profit before tax (PBT) of Medi Caps Ltd stood at Rs 2.23 crore in Q2 FY26, tanking 36.10% year-on-year, and tumbling by 173.60% quarter-on-quarter. EBITDA came in at Rs 2 crore, crashing by 49.19% YoY and plunging by 75.42% sequentially. Total expenses reduced by 15.64% to Rs 5.07 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 1.4 crore, going up by 18.64% YoY, while employee benefits expense was at Rs 1.91 crore, declining 11.98% YoY. For the TTM ended FY26, revenue from operations eased 4.48% to Rs 25.37 crore, while net profit tumbled by 74.55% to Rs 0.57 crore, compared to previous TTM. EBITDA tanked by 148% to Rs 4.56 crore, and PBT collapsed by 32.80% to Rs 0.84 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 5.07 crore in FY26, as against Rs 6.94 crore in FY25. Medi Caps Ltd crashed 39.29% in last one year, underperforming the benchmark BSE Sensex which has softened by 2.64% during the same period.
